STAT+: Pharmalittle: We’re reading about compounders suing the FDA, Biogen turning to telehealth, and more
STAT
OCTOBER 8, 2024
… A trade group representing large compounding pharmacies has sued the U.S. appeals court ruled 2-1 that Merck is immune from an antitrust lawsuit accusing it of misleading regulators about the effectiveness of its mumps vaccine in order to ward off competition, Reuters says.
Let's personalize your content